Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings
Stephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
The International Journal of Pharmacy Practice
|
April 13, 2022
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review
Klarissa A Sinnappah, Sophie L Stocker, Jian Sheng Chan, et al.
Clinical Pharmacokinetics
|
April 15, 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
Qing Xi Ooi, Daniel F B Wright, R Campbell Tait, et al.
Pharmacy (Basel, Switzerland)
|
May 15, 2020
Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance
Daniel F B Wright, Stephen B Duffull, Kyle J Wilby, et al.
The New Zealand Medical Journal
|
August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is needed
Stephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
British Journal of Clinical Pharmacology
|
March 6, 2014
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Paul K L Chin, Daniel F B Wright, David M Patterson, et al.
Drug Safety
|
August 3, 2019
The Association between Metformin Therapy and Lactic Acidosis
Isabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology
|
June 10, 2020
A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments
Emma H Baker, Danijela Gnjidic, Carl M J Kirkpatrick, et al.
British Journal of Clinical Pharmacology
|
October 10, 2015
Predicting allopurinol response in patients with gout
Daniel F B Wright, Stephen B Duffull, Tony R Merriman, et al.
Therapeutic Drug Monitoring
|
November 6, 2024
Untangling the Exposure-Response Relationship of Allopurinol in the Setting of Chronic Kidney Disease and Diuretic Use: Implications for Dosing
Hailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
CPT: Pharmacometrics & Systems Pharmacology
|
June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings
Stephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
The International Journal of Pharmacy Practice
|
April 13, 2022
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review
Klarissa A Sinnappah, Sophie L Stocker, Jian Sheng Chan, et al.
Clinical Pharmacokinetics
|
April 15, 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
Qing Xi Ooi, Daniel F B Wright, R Campbell Tait, et al.
Pharmacy (Basel, Switzerland)
|
May 15, 2020
Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance
Daniel F B Wright, Stephen B Duffull, Kyle J Wilby, et al.
The New Zealand Medical Journal
|
August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is needed
Stephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
British Journal of Clinical Pharmacology
|
March 6, 2014
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Paul K L Chin, Daniel F B Wright, David M Patterson, et al.
Drug Safety
|
August 3, 2019
The Association between Metformin Therapy and Lactic Acidosis
Isabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology
|
June 10, 2020
A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments
Emma H Baker, Danijela Gnjidic, Carl M J Kirkpatrick, et al.
British Journal of Clinical Pharmacology
|
October 10, 2015
Predicting allopurinol response in patients with gout
Daniel F B Wright, Stephen B Duffull, Tony R Merriman, et al.
Therapeutic Drug Monitoring
|
November 6, 2024
Untangling the Exposure-Response Relationship of Allopurinol in the Setting of Chronic Kidney Disease and Diuretic Use: Implications for Dosing
Hailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.
Page
of 8